CompletedNot Applicable

The Effect of Magnesium Use in Reversal of Neuromuscular Block With Sugammadex

Turkey (Türkiye)30 participantsStarted 2022-09-28

Plain-language summary

Magnesium therapy used for seizure prophylaxis in patients with preeclampsia. Magnesium has been shown to prolong the effect of nondepolarizing neuromuscular blocking agents (NMBA) and neostigmine used to reverse the effect of NMBA in general anesthesia . In this study, the investigators aimed to evaluate time from sugammadex injection to Train-of-four ratio 0.9 who receieved magnesium therapy in reversing the effect of neuromuscular blocking agent during the recovery period and the relationship between magnesium level and duration of action of sugammadex

Who can participate

Age range18 Years – 65 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Pregnant women who are scheduled for cesarean section under general anesthesia (pregnant women who do not use magnesium) and who use magnesium for prophylaxis in preeclampsia. Exclusion Criteria: * Eclampsia, * chronic hypertension, * connective tissue disorder, * muscle disease, neurological problems, * thyroid dysfunction, * kidney disease, heart disease, * patients with severe allergic reaction to the agents to be used, * sepsis, * hypovolemia, abruptio placenta, placenta previa, * conditions that will prolong the effect of muscle relaxants (drug use ), * pregnant women who did not want to be included in the study

What they're measuring

Recovery time

Timeframe: at end of surgery (Postoperative 2 hours)

Trial details

NCT IDNCT05558969

SponsorEskisehir Osmangazi University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-05-20

View on ClinicalTrials.gov More Magnesium Sulfate trials